Directrices de la Organización Mundial de la Salud del 2021 sobre el tratamiento farmacológico de la hipertensión: implicaciones de política para la Región de las Américas

Norm R.C. Campbell; Melanie Paccot Burnens; Paul K. Whelton; Sonia Y. Angell; Marc G. Jaffe; Jennifer Cohn; Alfredo Espinosa Brito; Vilma Irazola; Jeffrey W. Brettler; Edward J. Roccella; Javier Isaac Maldonado Figueredo; Andres Rosende; Pedro Ordunez

doi:10.1016/j.lana.2022.100219

Directrices de la Organización Mundial de la Salud del 2021 sobre el tratamiento farmacológico de la hipertensión: implicaciones de política para la Región de las Américas

Translated title of the contribution: 2021 World Health Organization guideline on pharmacological treatment of hypertension: Policy implications for the Region of the Americas

Norm R.C. Campbell, Melanie Paccot Burnens, Paul K. Whelton, Sonia Y. Angell, Marc G. Jaffe, Jennifer Cohn, Alfredo Espinosa Brito, Vilma Irazola, Jeffrey W. Brettler, Edward J. Roccella, Javier Isaac Maldonado Figueredo, Andres Rosende, Pedro Ordunez

Research output: Contribution to journal › Article › peer-review

Abstract

Cardiovascular disease (CVD) is the leading cause of death in the Americas and raised blood pressure accounts for over 50% of CVD. In the Americas over a quarter of adult women and four in ten adult men have hypertension and the diagnosis, treatment and control are suboptimal. In 2021, the World Health Organization (WHO) released an updated guideline for the pharmacological treatment of hypertension in adults. This policy paper highlights the facilitating role of the WHO Global HEARTS initiative and the HEARTS in the Americas initiative to catalyze the implementation of this guideline, provides specific policy advice for implementation, and emphasizes that an overarching strategic approach for hypertension control is needed. The authors urge health advocates and policymakers to prioritize the prevention and control of hypertension to improve the health and wellbeing of their populations and to reduce CVD health disparities within and between populations of the Americas.

Translated title of the contribution	2021 World Health Organization guideline on pharmacological treatment of hypertension: Policy implications for the Region of the Americas
Original language	Portuguese
Article number	e55
Journal	Revista Panamericana de Salud Publica/Pan American Journal of Public Health
Volume	46
DOIs	https://doi.org/10.1016/j.lana.2022.100219
State	Published - 2022
Externally published	Yes

Keywords

Américas
Hypertension
cardiovascular disease
clinical protocols
health policy
health services
practice guideline
public health

ASJC Scopus subject areas

Public Health, Environmental and Occupational Health

Access to Document

10.1016/j.lana.2022.100219

Cite this

Campbell, N. R. C., Burnens, M. P., Whelton, P. K., Angell, S. Y., Jaffe, M. G., Cohn, J., Brito, A. E., Irazola, V., Brettler, J. W., Roccella, E. J., Figueredo, J. I. M., Rosende, A., & Ordunez, P. (2022). Directrices de la Organización Mundial de la Salud del 2021 sobre el tratamiento farmacológico de la hipertensión: implicaciones de política para la Región de las Américas. Revista Panamericana de Salud Publica/Pan American Journal of Public Health, 46, Article e55. https://doi.org/10.1016/j.lana.2022.100219

Directrices de la Organización Mundial de la Salud del 2021 sobre el tratamiento farmacológico de la hipertensión: implicaciones de política para la Región de las Américas. / Campbell, Norm R.C.; Burnens, Melanie Paccot; Whelton, Paul K. et al.
In: Revista Panamericana de Salud Publica/Pan American Journal of Public Health, Vol. 46, e55, 2022.

Research output: Contribution to journal › Article › peer-review

Campbell, NRC, Burnens, MP, Whelton, PK, Angell, SY, Jaffe, MG, Cohn, J, Brito, AE, Irazola, V, Brettler, JW, Roccella, EJ, Figueredo, JIM, Rosende, A & Ordunez, P 2022, 'Directrices de la Organización Mundial de la Salud del 2021 sobre el tratamiento farmacológico de la hipertensión: implicaciones de política para la Región de las Américas', Revista Panamericana de Salud Publica/Pan American Journal of Public Health, vol. 46, e55. https://doi.org/10.1016/j.lana.2022.100219

Campbell NRC, Burnens MP, Whelton PK, Angell SY, Jaffe MG, Cohn J et al. Directrices de la Organización Mundial de la Salud del 2021 sobre el tratamiento farmacológico de la hipertensión: implicaciones de política para la Región de las Américas. Revista Panamericana de Salud Publica/Pan American Journal of Public Health. 2022;46:e55. doi: 10.1016/j.lana.2022.100219

@article{4d9a45c00fe44d219fb260d55bd588f6,

title = "Directrices de la Organizaci{\'o}n Mundial de la Salud del 2021 sobre el tratamiento farmacol{\'o}gico de la hipertensi{\'o}n: implicaciones de pol{\'i}tica para la Regi{\'o}n de las Am{\'e}ricas",

abstract = "Cardiovascular disease (CVD) is the leading cause of death in the Americas and raised blood pressure accounts for over 50% of CVD. In the Americas over a quarter of adult women and four in ten adult men have hypertension and the diagnosis, treatment and control are suboptimal. In 2021, the World Health Organization (WHO) released an updated guideline for the pharmacological treatment of hypertension in adults. This policy paper highlights the facilitating role of the WHO Global HEARTS initiative and the HEARTS in the Americas initiative to catalyze the implementation of this guideline, provides specific policy advice for implementation, and emphasizes that an overarching strategic approach for hypertension control is needed. The authors urge health advocates and policymakers to prioritize the prevention and control of hypertension to improve the health and wellbeing of their populations and to reduce CVD health disparities within and between populations of the Americas.",

keywords = "Am{\'e}ricas, Hypertension, cardiovascular disease, clinical protocols, health policy, health services, practice guideline, public health",

author = "Campbell, {Norm R.C.} and Burnens, {Melanie Paccot} and Whelton, {Paul K.} and Angell, {Sonia Y.} and Jaffe, {Marc G.} and Jennifer Cohn and Brito, {Alfredo Espinosa} and Vilma Irazola and Brettler, {Jeffrey W.} and Roccella, {Edward J.} and Figueredo, {Javier Isaac Maldonado} and Andres Rosende and Pedro Ordunez",

year = "2022",

doi = "10.1016/j.lana.2022.100219",

language = "Portuguese",

volume = "46",

journal = "Revista Panamericana de Salud Publica/Pan American Journal of Public Health",

issn = "1020-4989",

}

TY - JOUR

T1 - Directrices de la Organización Mundial de la Salud del 2021 sobre el tratamiento farmacológico de la hipertensión

T2 - implicaciones de política para la Región de las Américas

AU - Campbell, Norm R.C.

AU - Burnens, Melanie Paccot

AU - Whelton, Paul K.

AU - Angell, Sonia Y.

AU - Jaffe, Marc G.

AU - Cohn, Jennifer

AU - Brito, Alfredo Espinosa

AU - Irazola, Vilma

AU - Brettler, Jeffrey W.

AU - Roccella, Edward J.

AU - Figueredo, Javier Isaac Maldonado

AU - Rosende, Andres

AU - Ordunez, Pedro

PY - 2022

Y1 - 2022

N2 - Cardiovascular disease (CVD) is the leading cause of death in the Americas and raised blood pressure accounts for over 50% of CVD. In the Americas over a quarter of adult women and four in ten adult men have hypertension and the diagnosis, treatment and control are suboptimal. In 2021, the World Health Organization (WHO) released an updated guideline for the pharmacological treatment of hypertension in adults. This policy paper highlights the facilitating role of the WHO Global HEARTS initiative and the HEARTS in the Americas initiative to catalyze the implementation of this guideline, provides specific policy advice for implementation, and emphasizes that an overarching strategic approach for hypertension control is needed. The authors urge health advocates and policymakers to prioritize the prevention and control of hypertension to improve the health and wellbeing of their populations and to reduce CVD health disparities within and between populations of the Americas.

AB - Cardiovascular disease (CVD) is the leading cause of death in the Americas and raised blood pressure accounts for over 50% of CVD. In the Americas over a quarter of adult women and four in ten adult men have hypertension and the diagnosis, treatment and control are suboptimal. In 2021, the World Health Organization (WHO) released an updated guideline for the pharmacological treatment of hypertension in adults. This policy paper highlights the facilitating role of the WHO Global HEARTS initiative and the HEARTS in the Americas initiative to catalyze the implementation of this guideline, provides specific policy advice for implementation, and emphasizes that an overarching strategic approach for hypertension control is needed. The authors urge health advocates and policymakers to prioritize the prevention and control of hypertension to improve the health and wellbeing of their populations and to reduce CVD health disparities within and between populations of the Americas.

KW - Américas

KW - Hypertension

KW - cardiovascular disease

KW - clinical protocols

KW - health policy

KW - health services

KW - practice guideline

KW - public health

UR - http://www.scopus.com/inward/record.url?scp=85131794982&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85131794982&partnerID=8YFLogxK

U2 - 10.1016/j.lana.2022.100219

DO - 10.1016/j.lana.2022.100219

M3 - Article

C2 - 35573114

AN - SCOPUS:85131794982

SN - 1020-4989

VL - 46

JO - Revista Panamericana de Salud Publica/Pan American Journal of Public Health

JF - Revista Panamericana de Salud Publica/Pan American Journal of Public Health

M1 - e55

ER -

Directrices de la Organización Mundial de la Salud del 2021 sobre el tratamiento farmacológico de la hipertensión: implicaciones de política para la Región de las Américas

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this